Find therapies in clinical trials near you – page 26

Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer

Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer

Study on the Effects of Adding Durvalumab After Chemotherapy and Surgery in Patients with Resectable Non-Small Cell Lung Cancer

Study on the Effects of Adding Durvalumab After Chemotherapy and Surgery in Patients with Resectable Non-Small Cell Lung Cancer

Study on the Safety and Effects of Pegunigalsidase Alfa for Children and Adolescents with Fabry Disease

Study on the Safety and Effects of Pegunigalsidase Alfa for Children and Adolescents with Fabry Disease

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Study on the Effects of Ropivacaine and Lidocaine in Patients Receiving Cardiac Device Implants

Study on the Effects of Ropivacaine and Lidocaine in Patients Receiving Cardiac Device Implants

Study on the Effects of Ticagrelor and Acetylsalicylic Acid in Patients with Coronary Artery Disease Undergoing CABG Surgery

Study on the Effects of Ticagrelor and Acetylsalicylic Acid in Patients with Coronary Artery Disease Undergoing CABG Surgery

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Study of Tabelecleucel for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Transplant Treatment Failure

Study of Tabelecleucel for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Transplant Treatment Failure

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases

Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases